BlackRock’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,385,434
| Closed | -$7.7M | – | 5354 |
|
|
2024
Q2 | $7.7M | Buy |
1,385,434
+902,140
| +187% | +$3.2M | ﹤0.01% | 3518 |
|
|
2024
Q1 | $1.88M | Buy |
483,294
+39,455
| +9% | +$150K | ﹤0.01% | 4013 |
|
|
2023
Q4 | $1.92M | Buy |
443,839
+443,304
| +82,861% | +$1.5M | ﹤0.01% | 4055 |
|
|
2023
Q3 | $1.66K | Hold |
535
| – | – | ﹤0.01% | 5307 |
|
|
2023
Q2 | $1.56K | Sell |
535
-13,330
| -96% | -$30.6K | ﹤0.01% | 5382 |
|
|
2023
Q1 | $29.1K | Buy |
13,865
+438
| +3% | +$1.02K | ﹤0.01% | 5204 |
|
|
2022
Q4 | $36.4K | Buy |
13,427
+557
| +4% | +$2.37K | ﹤0.01% | 5285 |
|
|
2022
Q3 | $65K | Sell |
12,870
-13,128
| -50% | -$79.9K | ﹤0.01% | 5300 |
|
|
2022
Q2 | $143K | Sell |
25,998
-3,326
| -11% | -$18.3K | ﹤0.01% | 5126 |
|
|
2022
Q1 | $165K | Sell |
29,324
-729
| -2% | -$3.55K | ﹤0.01% | 5157 |
|
|
2021
Q4 | $154K | Buy |
30,053
+779
| +3% | +$3.81K | ﹤0.01% | 5163 |
|
|
2021
Q3 | $124K | Sell |
29,274
-65
| -0.2% | -$453 | ﹤0.01% | 5090 |
|
|
2021
Q2 | $267K | Buy |
29,339
+18,424
| +169% | +$181K | ﹤0.01% | 4839 |
|
|
2021
Q1 | $106K | Buy |
10,915
+436
| +4% | +$3.57K | ﹤0.01% | 4832 |
|
|
2020
Q4 | $44K | Buy |
10,479
+255
| +2% | +$1.14K | ﹤0.01% | 4690 |
|
|
2020
Q3 | $49K | Buy |
10,224
+3
| +0% | +$18 | ﹤0.01% | 4617 |
|
|
2020
Q2 | $64K | Sell |
10,221
-310
| -3% | -$1.62K | ﹤0.01% | 4549 |
|
|
2020
Q1 | $42K | Buy |
10,531
+570
| +6% | +$3.47K | ﹤0.01% | 4506 |
|
|
2019
Q4 | $75K | Buy |
9,961
+150
| +2% | +$896 | ﹤0.01% | 4487 |
|
|
2019
Q3 | $83K | Buy |
9,811
+154
| +2% | +$1.4K | ﹤0.01% | 4472 |
|
|
2019
Q2 | $129K | Sell |
9,657
-9,618
| -50% | -$135K | ﹤0.01% | 4431 |
|
|
2019
Q1 | $307K | Sell |
19,275
-117
| -0.6% | -$1.78K | ﹤0.01% | 4177 |
|
|
2018
Q4 | $209K | Buy |
19,392
+559
| +3% | +$8.15K | ﹤0.01% | 4216 |
|
|
2018
Q3 | $277K | Buy |
18,833
+683
| +4% | +$10.4K | ﹤0.01% | 4258 |
|
|
2018
Q2 | $266K | Buy |
18,150
+4,022
| +28% | +$56.6K | ﹤0.01% | 4250 |
|
|
2018
Q1 | $219K | Buy |
14,128
+69
| +0.5% | +$1.22K | ﹤0.01% | 4189 |
|
|
2017
Q4 | $281K | Buy |
14,059
+605
| +4% | +$11.8K | ﹤0.01% | 4145 |
|
|
2017
Q3 | $273K | Buy |
13,454
+133
| +1% | +$2.85K | ﹤0.01% | 4167 |
|
|
2017
Q2 | $277K | Buy |
13,321
+476
| +4% | +$10.2K | ﹤0.01% | 4175 |
|
|
2017
Q1 | $269K | Buy |
+12,845
| New | +$247K | ﹤0.01% | 4139 |
|
|
2016
Q2 | – | Sell |
-73
| Closed | -$2K | – | 3842 |
|
|
2016
Q1 | $2K | Buy |
73
+31
| +74% | +$965 | ﹤0.01% | 3473 |
|
|
2015
Q4 | $2K | Hold |
42
| – | – | ﹤0.01% | 3336 |
|
|
2015
Q3 | $1K | Hold |
42
| – | – | ﹤0.01% | 3191 |
|
|
2015
Q2 | $3K | Hold |
42
| – | – | ﹤0.01% | 3192 |
|
|
2015
Q1 | $3K | Buy |
+42
| New | +$3.31K | ﹤0.01% | 3105 |
|
BlackRock's ALIM Position: Q3 2024 in Review
BlackRock sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 1,385,434 shares — an estimated $7.7M sold.
BlackRock first reported a position in ALIM in Q1 2015 and held it in 35 quarters. The position peaked at $7.7M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- BlackRock reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- BlackRock sold 1,385,434 Alimera Sciences shares in Q3 2024, an estimated $7.7M.
- BlackRock first reported a position in Alimera Sciences in Q1 2015 and held it in 35 quarters.
- BlackRock's Alimera Sciences position peaked at $7.7M in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.